Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alexander Renziehausen

1PUBLICATIONS
16CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 02, 2022
Inhibition of the angiotensin II type 2 receptor AT<sub>2</sub>R is a novel therapeutic strategy for glioblastoma.

Richard Perryman, Alexander Renziehausen, Hamidreza Shaye

Pageof 1

Frequent Collaborators

1 joint publications

Hamidreza Shaye

1 joint publications

Thomas Thorne

1 joint publications

Maria V Chatziathanasiadou

1 joint publications

Gregory B Sivolapenko

1 joint publications

Mohamed Ahmed El Mubarak

1 joint publications

Gye Won Han

1 joint publications

Vsevolod Katritch

1 joint publications

Guillaume Lebon

1 joint publications

Cristiana Lo Nigro

1 joint publications

Sophie V Morse

Frequent Collaborators

1 joint publications

Hamidreza Shaye

1 joint publications

Thomas Thorne

1 joint publications

Maria V Chatziathanasiadou

1 joint publications

Gregory B Sivolapenko

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.5K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.5K
See more related videos